HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Nasal Cavity Cancer

Nasal Cavity Cancer

Nasal cavity cancer, though rare, poses significant challenges due to its complex anatomy and late diagnosis. Current cancer research endeavors focus on several fronts. Early detection methods, such as advanced imaging techniques and biomarker identification, are being explored to improve prognosis. Treatment modalities, including surgery, radiation therapy, and chemotherapy, are undergoing refinement to enhance efficacy while minimizing side effects. Immunotherapy, a promising avenue in cancer treatment, is being investigated to harness the body's immune system to target cancer cells specifically. Additionally, genetic studies aim to unravel the molecular mechanisms underlying nasal cavity cancer, paving the way for targeted therapies. Collaborative efforts between researchers, clinicians, and pharmaceutical companies are crucial in advancing our understanding and management of this challenging disease.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp